Lv75
3810 积分 2023-10-05 加入
Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies
1天前
已完结
Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies
1天前
已关闭
Significant Cytokine Release Syndrome Risk Model with T-Cell Engaging Therapies
1天前
已关闭
Free Drug Theory – No Longer Just a Hypothesis?
4天前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
7天前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
7天前
已完结
A Luciferase Reporter Assay to Detect Cellular Hypoxia In Vitro
11天前
已完结
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
11天前
已完结
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
21天前
已完结
Considerations in Kp,uu,brain-based Strategy for Selecting CNS-targeted Drug Candidates with Sufficient Target Coverage and Substantial Pharmacodynamic Effect
25天前
已完结
皖公网安备34019202002308
